Indications and Uses of Mometasone Furoate 0.1% Cream
Mometasone furoate 0.1% cream is FDA-approved for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age and older. 1
Primary Indications
Atopic Dermatitis (Eczema)
Mometasone furoate 0.1% cream is classified as a medium-potency topical corticosteroid and serves as an effective treatment option for atopic dermatitis across multiple age groups. 2
Pediatric patients (1-12 months): In infants with facial atopic dermatitis, mometasone furoate 0.1% cream applied twice daily for 10 days demonstrated safety comparable to vehicle, with significant improvements in EASI scores, itch response, and quality of life 2
Children and adolescents: Effective for moderate-to-severe atopic dermatitis when applied twice daily 2
Maintenance therapy: Medium-potency topical corticosteroids like mometasone can be used up to 3 times per week for maintenance therapy in patients with frequently relapsing disease to reduce flares and increase comfort 2
Psoriasis
Mometasone furoate 0.1% cream demonstrates efficacy in psoriasis management:
Psoriasis vulgaris: Applied once daily for 2-8 weeks, mometasone 0.1% was generally more effective than other corticosteroids of similar or weaker potency 3
Combination therapy: When combined with tazarotene gel, mometasone cream showed superior efficacy compared to mometasone alone, both during therapy and for duration of therapeutic effect 4
The mometasone ointment formulation (0.1%) is classified as high-potency (Class II), while the cream formulation is medium-potency (Class III-IV) 2, 5
Other Corticosteroid-Responsive Dermatoses
Mometasone furoate 0.1% cream is effective for:
Seborrheic dermatitis: More effective than ketoconazole 2.0% and hydrocortisone 1.0% in 4-6 week trials 3
Allergic contact dermatitis: Demonstrated 93.6% average improvement after 21 days of once-daily application 6
Lichen sclerosus: Effective alternative to clobetasol propionate with similar efficacy but potentially higher safety profile 7, 8
Lichen simplex chronicus: Effective treatment, particularly when used under hydrocolloid dressing 9
Dosing and Application
Apply a thin film once daily to affected skin areas. 1
Key Dosing Considerations:
Pediatric use: Approved for children ≥2 years of age; safety and efficacy for >3 weeks use not established in pediatric patients 1
Not recommended: Children <2 years of age 1
Discontinue therapy when control is achieved; if no improvement within 2 weeks, reassess diagnosis 1
Avoid occlusive dressings unless directed by physician 1
Do not apply in diaper area if child requires diapers or plastic pants 1
Anatomical Site Considerations
Use lower potency agents on face, neck, genitals, and body folds due to increased absorption and atrophy risk in these areas. 2 The cream formulation of mometasone (medium potency) is more appropriate for these sensitive areas compared to the ointment formulation (high potency).
Safety Profile
Mometasone furoate demonstrates a favorable benefit-to-risk ratio:
Low HPA axis suppression potential: Approximately half as potent as betamethasone valerate in suppressing hypothalamic-pituitary-adrenal axis function 3, 10
Low atrophogenic potential: No greater than other corticosteroids in its class 3
Well-tolerated: Transient, mild-to-moderate local adverse effects (burning, stinging, folliculitis, dryness) may occur 3
Low sensitization risk: Preliminary patch test studies show low risk of primary sensitization and cross-reactions 3
Common Pitfalls to Avoid
Steroid phobia: Educate patients that when used appropriately, topical corticosteroids are safe and effective; patient concerns average 6.5/10 on distress scales 2
Inappropriate potency selection: Remember the cream formulation is medium-potency (Class III-IV), while the ointment is high-potency (Class II) 2
Overuse in young children: Limit use to ≤3 weeks in pediatric patients without established long-term safety data 1
Occlusion in infants: Never use under diapers or plastic pants as these create occlusive conditions 1